Cboe CA - Delayed Quote CAD
Roche Holding AG (ROG.NE)
20.82
+0.48
+(2.36%)
At close: April 24 at 3:57:54 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
20,094,000
20,094,000
16,095,000
17,803,000
20,976,000
Investing Cash Flow
-11,393,000
-11,393,000
-10,643,000
-2,924,000
-6,552,000
Financing Cash Flow
-6,819,000
-6,819,000
-4,239,000
-16,275,000
-13,108,000
End Cash Position
6,975,000
6,975,000
5,376,000
4,991,000
6,850,000
Capital Expenditure
-5,009,000
-5,009,000
-4,649,000
-4,552,000
-4,549,000
Issuance of Capital Stock
-1,130,000
-1,130,000
-1,144,000
-1,257,000
-1,406,000
Issuance of Debt
7,915,000
7,915,000
8,342,000
8,442,000
20,312,000
Repayment of Debt
-3,387,000
-3,387,000
-1,751,000
-15,433,000
-2,448,000
Repurchase of Capital Stock
--
--
--
--
-18,991,000
Free Cash Flow
15,085,000
15,085,000
11,446,000
13,251,000
16,427,000
12/31/2021 - 2/19/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NVS.NE NOVARTIS CDR (CAD HEDGED)
21.68
+1.17%
MRK.NE Merck & Co., Inc.
18.28
+0.88%
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
6.73
+2.75%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.44
-0.20%
PFE.NE Pfizer Inc.
10.50
+2.24%
LLY.NE Eli Lilly and Company
31.75
+3.66%
NVS Novartis AG
111.17
+0.94%
MRK Merck & Co., Inc.
79.84
+1.40%
BMY Bristol-Myers Squibb Company
48.69
+0.33%
ABBV AbbVie Inc.
180.37
+1.88%